Heart Rate Variability and Stress Management Enhancement

Sponsor
Joseph Maroon (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT04381182
Collaborator
Apollo Neuro (Other)
20
1
1
11.6
1.7

Study Details

Study Description

Brief Summary

This study will be conducted by using two devices (Apollo and Biostrap) for monitoring of baseline physiologic variables and heart rate variability. The biostrap will be worn by residents and will monitor heart rate, heart rate variability, respiratory rate, sleep patterns, steps, etc. The Apollo is a pulse generator device aimed at modulating heart rate variability for (hopefully) reduction in stress and improving performance in and around the hospital. Resident neurosurgeons will wear the biostrap for a two week cycle and follow that with the addition of the Apollo device for heart rate variability modulation.

Condition or Disease Intervention/Treatment Phase
  • Device: Apollo Wearable Device
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Impact of Heart Rate Variability Modulation on Stress and Performance Among Neurosurgical Residents
Actual Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Jul 20, 2022
Anticipated Study Completion Date :
Aug 20, 2022

Arms and Interventions

Arm Intervention/Treatment
Other: Biostrap/Apollo Device Use

Participants wear a Biostrap wearable device which measures steps, heart rate, heart rate variability, sleep metrics, and quantitative data in typical day-to-day activities of residents. Participants then again wear Biostrap except now also with the Apollo device which is worn around the ankle and is suggested to modulate heart rate variability and perceived stress of participants.

Device: Apollo Wearable Device
Participants wear Apollo device which generates vibration frequencies on skin and can be controlled by the user

Outcome Measures

Primary Outcome Measures

  1. Change from baseline to two month heart rate variability [Baseline, Two Month. Analyzed via paired t-test and assessing change between each outcome time point]

    Quantitative (average range, beats per minute)

  2. Change from baseline to two month Perceived Stress Scale [Baseline, Two Month. Analyzed via paired t-test and assessing change between each outcome time point]

    Questionnaire, 14 point form/scale ranging from 0-50 with higher scores signifiying increased stress

  3. Change from baseline to two month Quick Inventory of Depressive Symptomatology (QIDS) [Baseline, Two Month. Analyzed via paired t-test and assessing change between each outcome time point]

    Questionnaire ranging from 0-27 and measuring major depressive symptomatology. Higher scores signify more severe depression.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Neurosurgical Resident (UPMC)
Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC Presbyterian Hospital Department of Neurological Surgery Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • Joseph Maroon
  • Apollo Neuro

Investigators

  • Principal Investigator: Joseph Maroon, Department of Neurological Surgery

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joseph Maroon, Clinical Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04381182
Other Study ID Numbers:
  • STUDY19020291
First Posted:
May 8, 2020
Last Update Posted:
Sep 10, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 10, 2021